arrow
S

Sián Fereday

Peter MacCallum Cancer Centre
H指数:55
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma

BRCA缺陷性输卵管卵巢高级别浆液性癌的生存临床病理及分子预测因子

2026-04-010
OAAI
Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival

输卵管卵巢高级别浆液性癌患者结局的临床与分子预测因子及特殊生存情况

2024-09-010
PRE
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
2023-06-203
OAAI
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

p53和卵巢癌生存: 卵巢肿瘤组织分析联盟研究

2023-03-2210
OAAI
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer

同源重组缺陷型终末期高级别浆液性卵巢癌的多组学分析

2023-02-2728
PRE
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

CCNE1与输卵管卵巢高级别浆液性癌患者的生存: 卵巢肿瘤组织分析联盟研究

CANCER
IF5.1
2022-12-2614
OAAI
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
2022-12-0135
OA
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

高级别浆液性卵巢癌中FOXJ1蛋白表达增加与总生存期改善相关: 卵巢肿瘤组织分析联盟研究

2022-11-023
OA
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

高诊断前炎症相关风险评分与卵巢癌生存率降低相关

2022-02-073
OA
Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

鉴定与卵巢癌无进展生存期相关的ULK1附近基因座

2021-06-237
OA
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

高级别浆液性卵巢癌分子亚型 (前型) 基因表达预测因子的建立与验证

2020-10-1550
OAAI
Prognostic gene expression signature for high-grade serous ovarian cancer

高级别浆液性卵巢癌的预后基因表达特征

2020-09-0186
OAAI
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
2020-06-1842
OAAI
The molecular origin and taxonomy of mucinous ovarian carcinoma

卵巢粘液性癌的分子起源和分类

2019-09-02112
OAAI
Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype
2019-07-0129
OAAI